SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 198 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $133,230 | -40.2% | 75,699 | +6.6% | 0.00% | -50.0% |
| Q4 2022 | $222,959 | -53.1% | 71,006 | -26.9% | 0.00% | -55.6% |
| Q3 2022 | $475,000 | +446.0% | 97,115 | +361.0% | 0.01% | +350.0% |
| Q2 2022 | $87,000 | -82.2% | 21,068 | -74.9% | 0.00% | -84.6% |
| Q1 2022 | $488,000 | +373.8% | 83,973 | +632.4% | 0.01% | +333.3% |
| Q3 2021 | $103,000 | -75.3% | 11,465 | -57.1% | 0.00% | -89.3% |
| Q4 2020 | $417,000 | -70.9% | 26,700 | -80.0% | 0.03% | -82.3% |
| Q2 2019 | $1,434,000 | +52.1% | 133,199 | +34.8% | 0.16% | +1.9% |
| Q1 2019 | $943,000 | – | 98,800 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIC CAPITAL INC | 875,284 | $2,670,000 | 1.34% |
| NEXTHERA CAPITAL LP | 503,000 | $1,534,000 | 0.90% |
| Opaleye Management Inc. | 400,000 | $1,220,000 | 0.72% |
| WASATCH ADVISORS LP | 7,256,260 | $22,132,000 | 0.33% |
| Cormorant Asset Management, LP | 650,000 | $1,983,000 | 0.27% |
| Sicart Associates LLC | 101,950 | $311,000 | 0.22% |
| Baker Brothers Advisors | 4,055,876 | $12,370,000 | 0.12% |
| Leisure Capital Management | 43,008 | $131,000 | 0.12% |
| Piermont Capital Management Inc. | 165,569 | $505,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 837,963 | $2,556,000 | 0.10% |